Cargando…

Improvement of left ventricular function after percutaneous coronary intervention in patients with stable coronary artery disease and preserved ejection fraction: Impact of diabetes mellitus

BACKGROUND: Many patients with stable coronary artery disease (CAD) have no visual segmental wall motion abnormalities and a left ventricular (LV) ejection fraction (LVEF) ≥ 50% at rest despite significant coronary artery stenosis. Here, the aim was to determine the impact of percutaneous coronary i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikora-Frac, Malgorzata, Zaborska, Beata, Maciejewski, Pawel, Budaj, Andrzej, Bednarz, Bronislaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2019
Materias:	Clinical Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747832/ https://www.ncbi.nlm.nih.gov/pubmed/31257568 http://dx.doi.org/10.5603/CJ.a2019.0066

Ejemplares similares

Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity
por: Zaborska, Beata, et al.
Publicado: (2020)

The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
por: Zaborska, Beata, et al.
Publicado: (2023)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Chronotropic Incompetence Limits Aerobic Exercise Capacity in Patients Taking Beta-Blockers: Real-Life Observation of Consecutive Patients
por: Smarz, Krzysztof, et al.
Publicado: (2021)

Echocardiographic predictors of exercise intolerance in patients with heart failure with severely reduced ejection fraction
por: Zaborska, Beata, et al.
Publicado: (2018)

Global Longitudinal Strain as an Efficient Prognostic Tool in Hypertrophic Cardiomyopathy With Preserved Left Ventricular Ejection Fraction
por: Battel, Owen, et al.
Publicado: (2022)

Left Ventricular Ejection Fraction along with Zwolle Risk Score for Risk Stratification to Enhance Safe and Early Discharge in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Observational Study
por: Banga, Sandeep, et al.
Publicado: (2019)

Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?
por: Ahmed, Talha
Publicado: (2020)

Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety
por: Elkammash, Amr, et al.
Publicado: (2023)

Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Jyotsna, FNU, et al.
Publicado: (2023)

Severe degenerative aortic stenosis with preserved ejection fraction does not change adipokines serum levels
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2019)

Role of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction: A Review Article
por: Mgbemena, Okechukwu, et al.
Publicado: (2021)

Physician Variability in Diastology Reporting in Patients With Preserved Ejection Fraction: A Single Center Experience
por: Patel, Raj, et al.
Publicado: (2020)

Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
por: Baral, Nischit, et al.
Publicado: (2020)

The Impact of Using a Larger Forearm Artery for Percutaneous Coronary Interventions on Hand Strength: A Randomized Controlled Trial
por: Lewandowski, Pawel, et al.
Publicado: (2021)

Left Ventricular Thrombus Formation in a Young Female With a Severely Reduced Left Ventricular Ejection Fraction and a Recent Non-ST Segment Elevation-Acute Coronary Syndrome
por: Patel, Keshav R, et al.
Publicado: (2021)

Improving risk stratification in heart failure with preserved ejection fraction by combining two validated risk scores
por: Boralkar, Kalyani Anil, et al.
Publicado: (2019)

The Value of Neutrophil-to-Lymphocyte Ratio and Epicardial Adipose Tissue Thickness in Heart Failure With Preserved Ejection Fraction
por: Colluoglu, Tugce, et al.
Publicado: (2023)

Diurnal Variation in Outcomes of Percutaneous Coronary Intervention
por: Malik, Jahanzeb, et al.
Publicado: (2020)

Right Coronary Artery Pseudoaneurysm With Hemopericardium: A Rare Complication of Percutaneous Coronary Intervention
por: Byrnes, Sean, et al.
Publicado: (2020)

Impact of Hypothyroidism on Outcomes of Percutaneous Coronary Intervention with Coronary Atherectomy for Calcified Coronary Lesions: A Propensity-matched Analysis
por: Desai, Rupak, et al.
Publicado: (2018)

Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Baral, Nischit, et al.
Publicado: (2021)

Association of Major Depressive Disorder on Heart Failure With Reduced and Preserved Ejection Fraction: Analysis of National Readmission Database 2018
por: Thyagaturu, Harshith S, et al.
Publicado: (2021)

Inadvertent Septal Ablation During Percutaneous Coronary Intervention
por: Gao, Feng, et al.
Publicado: (2021)

The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease
por: Gupta, Amit, et al.
Publicado: (2018)

One Year Outcomes After Percutaneous Coronary Intervention in Diabetics With Stable Ischemic Heart Disease: A Single-Center Comparative Study
por: Adil, Muhammad, et al.
Publicado: (2021)

Ticagrelor-induced Diarrhea in a Patient with Acute Coronary Syndrome Requiring Percutaneous Coronary Artery Intervention
por: Alomari, Mohammad, et al.
Publicado: (2019)

Association Between Myocardial Scar Burden and Left Ventricular Ejection Fraction in Ischemic Cardiomyopathy
por: Aboul Enein, Fatma, et al.
Publicado: (2020)

Isolated Flailed P3 Scallop of the Mitral Valve Leaflet in the Setting of Newly Diagnosed Heart Failure With Preserved Ejection Fraction
por: Salas Noain, Jesus, et al.
Publicado: (2020)

Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Jiang, Ping, et al.
Publicado: (2019)

A Case Report of High-Risk Percutaneous Coronary Intervention of Left Main Coronary Artery With Cardiogenic Shock
por: Khanal, Suraj, et al.
Publicado: (2023)

Current Practice of Percutaneous Coronary Intervention in Patients With Coagulation Disorders
por: El Khoury, Michel, et al.
Publicado: (2021)

A Case Of Awake Percutaneous Extracorporeal Membrane Oxygenation For High-risk Percutaneous Coronary Intervention
por: Liu, Shuangbo, et al.
Publicado: (2017)

The Use of CT Coronary Angiography and CT Fractional Flow Reserve in the Investigation of Patients With Suspected Coronary Artery Disease
por: Khattak, Mohammad Fawad, et al.
Publicado: (2020)

The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction
por: Medeiros, Paulo, et al.
Publicado: (2023)

Multivessel Coronary Artery Disease and Subsequent Thrombolysis in Myocardial Infarction Flow Grade After Primary Percutaneous Coronary Intervention
por: Majeed, Haris, et al.
Publicado: (2020)

Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis
por: Nso, Nso, et al.
Publicado: (2022)

Chronic Total Occlusion of the Left Main Coronary Artery With Preserved Left Ventricular Systolic Function Presenting as a Chronic Coronary Syndrome: A Case Report and Brief Review
por: Aydın, Sidar Şiyar
Publicado: (2023)

QRS duration and cardiovascular mortality in Asian patients with heart failure and preserved and reduced ejection fraction
por: Yap, Jonathan, et al.
Publicado: (2021)

Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention
por: Aw, Kah Long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ecfp7qf1j6h3v29c0masib46bc